高乐氏保健品与epa批准的声明反对CRE
A number of 高乐氏医疗 disinfectants have EPA-approved claims against some common CRE.
参考文献
1. 疾病控制和预防中心. 跟踪CRE. http://www.cdc.gov/hai/organisms/cre/trackingcre.html
2. 疾病控制和预防中心. 耐碳青霉烯类肠杆菌科(CRE)感染:临床医师常见问题. http://www.cdc.gov/hai/organisms/cre/cre-clinicianfaq.html
3. Bhargava A等人. Risk Factors for Colonization due to Carbapenem-Resistant 肠杆菌属iaceae among Patients Exposed to Long-Term 急症护理 and 急症护理 Facilities. 感染控制 and Hospital Epidemiology, 2014; 35(4): 398-405.
4. 美国疾病控制与预防中心声明:洛杉矶县/加州大学洛杉矶分校对CRE传播和十二指肠镜的调查. 2015年7月10日,. http://www.cdc.gov/hai/outbreaks/cdcstatement-la-cre.html
5. Lerner A等人. 耐碳青霉烯肠杆菌科对环境的污染. 中国Microbiol. 2013; 51(1): 177–181.
6. Kizny A等. The Hospital Water Environment as a Reservoir for Carbapenem-Resistant Organisms Causing Hospital-Acquired Infections—A Systematic Review of the Literature. 临床感染疾病. 2018; 64:1435-1444.
7. 德盖特等人. The sink as a potential source of transmission of carbapenemase-producing 肠杆菌属iaceae in the intensive care unit. Antimicrobial Resistance and 感染控制, 2017; 6:24-29.
8. 雷吉夫-尤凯等. 汇阱作为oxa -48生产的传输源 粘质沙雷氏菌 在重症监护室. 感染控制 & Hospital Epidemiology 2018; 39:1307–1315.
9. 疾病控制和预防中心. Facility Guidance for Control of Carbapenem-resistant 肠杆菌属iaceae (CRE) November 2015 Update – CRE Toolkit. http://www.cdc.gov/hai/pdfs/cre/CRE-guidance-508.pdf
